Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension.

BMC Neurol · 2017 · PMC5427571 · PMID 28494751

Europe PMC DOI

hedged sentences

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

a strong trendP = 0.054so close (0.05 < p ≤ 0.1)

These reasons may also explain the differences noted by sex (i.e., droxidopa appearing to be less effective in women, although a strong trend was still noted [ P = 0.054]).

also in 5,725 other papers

did not reach statistical significanceno p-value reported

4b ); the improvement in the remaining 2 symptom items did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.